The PROMOTE (Patient-Reported Outcomes Measurement Opportunities Through Equity) study asked endometrial cancer survivors their opinion on their quality of life and any symptoms from endometrial cancer and/or its treatment. 

Historically, this knowledge around a patient’s experience of their cancer and its treatment was gathered via a survey. However, this survey was developed in populations that were not very diverse. 

We hope PROMOTE can potentially improve upon a clinically meaningful survey that impacts how doctors treat patients and reflects the symptoms and concerns identified as most important by diverse women who have had endometrial cancer treatment within the past 3 years. 

We have completed enrollment for this study. We are currently analyzing data and will publicly share study findings in the near future. PROMOTE Study data will generate a new, efficient, contemporary tool that assesses endometrial cancer patients' symptoms and quality of life to support patients' care. 

MANY THANKS to all of our study participants and who generously shared their experience, and to clinicians who assisted with recruitment. These efforts will help improve outcomes for other endometrial cancer patients in the future.